Nathaniel K. Mullin

Papers

Total Citations

H-Index

About

Dr. Nathaniel K. Mullin is pioneering the automation of regenerative medicine, with a focused mission to cure inherited blindness. His research lies at the critical intersection of stem cell biology, tissue engineering, and high-throughput biomanufacturing. Dr. Mullin’s most impactful contribution is his work on automating the production of induced pluripotent stem cells (iPSCs) to enable autologous photoreceptor cell replacement therapy. His landmark 2023 paper, which has garnered 30 citations, directly addresses the central bottleneck in the field: the lack of scalable technologies for generating patient-specific retinal cells. By developing robotic and microfluidic systems for parallel iPSC generation, Dr. Mullin is transforming a theoretically promising treatment for retinal degeneration into a practical, clinical reality. His work is not merely incremental; it is foundational for the entire field of personalized cell therapy. For any student or researcher interested in how engineering principles can solve the most pressing challenges in regenerative ophthalmology, Dr. Mullin’s research represents the essential blueprint for moving from the lab bench to the patient bedside.